Neuropsychiatric Disease and Treatment

Scope & Guideline

Fostering Global Collaboration in Neuropsychiatric Research

Introduction

Delve into the academic richness of Neuropsychiatric Disease and Treatment with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationNEUROPSYCH DIS TREAT / Neuropsychiatr. Dis. Treat.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal "Neuropsychiatric Disease and Treatment" aims to advance knowledge in the field of neuropsychiatry through high-quality research and clinical studies. Its scope encompasses a broad range of topics related to neuropsychiatric disorders and treatments, emphasizing both biological and psychosocial aspects of mental health.
  1. Neurodevelopmental Disorders:
    Research focusing on conditions such as Autism Spectrum Disorder and ADHD, examining their prevalence, diagnosis, and treatment strategies across diverse populations.
  2. Neuroinflammation and Neurodegeneration:
    Studies investigating the role of inflammatory processes in neurodegenerative diseases like Alzheimer's, Parkinson's, and stroke, including potential therapeutic interventions.
  3. Psychiatric Disorders and Comorbidity:
    Exploration of the interplay between psychiatric disorders, such as depression and anxiety, with chronic medical conditions, emphasizing their shared pathophysiology.
  4. Innovative Treatment Approaches:
    Research on novel therapeutic strategies, including pharmacological advancements (e.g., new antipsychotics, ketamine for depression) and non-pharmacological interventions (e.g., acupuncture, neurostimulation techniques).
  5. Cognitive and Behavioral Outcomes:
    Studies assessing cognitive functions and behavioral symptoms in various populations, particularly in relation to treatment efficacy and quality of life.
  6. Public Health and Epidemiology:
    Research highlighting the impact of socio-economic factors, health systems, and public health initiatives on mental health outcomes and treatment access.
Recent publications in "Neuropsychiatric Disease and Treatment" have highlighted several emerging themes that reflect the evolving landscape of neuropsychiatric research and treatment methodologies.
  1. Biomarkers and Precision Medicine:
    There is an increasing focus on identifying biomarkers for neuropsychiatric disorders, aiming for personalized treatment approaches that cater to individual patient profiles.
  2. Gut-Brain Axis Research:
    Emerging studies investigating the relationship between gut microbiota and neuropsychiatric conditions are gaining traction, indicating a trend towards exploring holistic and integrative treatment options.
  3. Digital Health Interventions:
    The rise of technology-assisted therapies, including mobile health applications and telepsychiatry, is becoming a prominent area of research, particularly in light of the COVID-19 pandemic.
  4. Neurostimulation Techniques:
    Innovations in non-invasive brain stimulation methods, such as transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT), are being increasingly explored for their therapeutic potential.
  5. Social Determinants of Mental Health:
    Research is increasingly addressing the impact of socio-economic and environmental factors on mental health, reflecting a broader understanding of mental health determinants.

Declining or Waning

While "Neuropsychiatric Disease and Treatment" has a diverse range of focuses, certain themes appear to be less prominent in recent publications, indicating a potential waning interest or shift in research priorities.
  1. Traditional Psychotherapies:
    There seems to be a decrease in the emphasis on traditional psychotherapy methods compared to emerging integrative approaches or pharmacological treatments, reflecting a shift towards more biologically-oriented research.
  2. Longitudinal Studies in General Populations:
    Fewer studies are being published that focus on longitudinal analyses within general populations, which may suggest a trend towards more specific clinical trials or targeted research.
  3. Animal Models in Neuroscience Research:
    While animal studies remain important, there is a noticeable decline in the number of publications utilizing these models, possibly due to a growing preference for human-centric research methodologies.
  4. Neuropsychological Assessments:
    Research centered on traditional neuropsychological testing may be declining as newer, more integrated approaches to assess cognitive and emotional health are being favored.

Similar Journals

Applied Neuropsychology-Adult

Advancing understanding in adult neuropsychology.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 2327-9095Frequency: 6 issues/year

Applied Neuropsychology-Adult is a premier journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to advancing the field of neuropsychology with a particular focus on adult populations. Since its inception in 2012, this journal has been a vital platform for disseminating innovative research, reviews, and clinical insights into the cognitive and psychological processes that influence adult behavior and functioning. With an impressive Scopus ranking, including Q3 status in both Developmental and Educational Psychology and Neuropsychology and Physiological Psychology, it demonstrates a commitment to high-quality scholarship that informs both clinical practice and theoretical understanding. Researchers, clinicians, and students alike will benefit from the journal's commitment to open access, providing broad access to valuable knowledge in the domain of neuropsychology. As it converges towards its 2024 milestone, Applied Neuropsychology-Adult continues to be an essential resource for those seeking to deepen their understanding of neuropsychological processes and their application in real-world settings.

Noropsikiyatri Arsivi-Archives of Neuropsychiatry

Connecting Minds: The Intersection of Neuroscience and Psychiatry
Publisher: TURKISH NEUROPSYCHIATRY ASSOC-TURK NOROPSIKIYATRI DERNEGIISSN: 1300-0667Frequency: 4 issues/year

Noropsikiyatri Arsivi-Archives of Neuropsychiatry is a prominent scholarly journal dedicated to advancing knowledge in the fields of neuropsychiatry and mental health. Published by the Turkish Neuropsychiatry Association, this journal aims to disseminate high-quality research that contributes to a deeper understanding of psychiatric disorders, innovative treatment modalities, and interdisciplinary approaches in neuroscience. Based in Turkey, the journal has been in circulation since its inception, with a rich history reflecting its commitment to addressing contemporary issues in mental health care. It is currently indexed under Scopus, with notable rankings in both Psychiatry and Mental Health (Rank #378/567, 33rd Percentile) and General Neuroscience (Rank #97/113, 14th Percentile), highlighting its increasing relevance and impact in the academia. Although it is not currently an open access journal, its contributions remain vital for researchers, professionals, and students who wish to stay abreast of the latest developments and research in neuropsychiatry.

PSYCHIATRIC GENETICS

Advancing Insights into Psychiatric Disorders through Genetics
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0955-8829Frequency: 6 issues/year

PSYCHIATRIC GENETICS, published by LIPPINCOTT WILLIAMS & WILKINS, is a pivotal journal dedicated to the interdisciplinary study of genetic factors in psychiatric disorders, bridging the fields of genetics, psychiatry, and neuroscience. With a commitment to advancing research from its inception in 1990 and continuing through 2024, the journal provides a platform for innovative studies and findings that explore the genetic underpinnings of mental health. Although not currently an Open Access publication, it reaches a wide audience concerned with the complex interplay between genetics and psychiatric conditions, contributing to its Q3 and Q2 quartile rankings across multiple relevant categories in 2023. The importance of this journal cannot be understated; it serves as a crucial resource for researchers, clinicians, and students eager to uncover insights that could lead to more effective interventions and treatments in the realm of mental health.

Journal of Attention Disorders

Connecting research and practice in attention disorders.
Publisher: SAGE PUBLICATIONS INCISSN: 1087-0547Frequency: 8 issues/year

The Journal of Attention Disorders is a premier peer-reviewed publication dedicated to advancing the understanding and treatment of attention-related disorders. Published by SAGE Publications Inc, this esteemed journal has become a vital resource in the fields of Clinical Psychology and Developmental and Educational Psychology, consistently ranking in the Q1 quartile for both categories as of 2023. With a significant impact factor and a commendable Scopus rank—#37 in Developmental and Educational Psychology and #34 in Clinical Psychology—this journal fosters innovative research and evidence-based practices that contribute to the mental health field. Since its inception in 1996, the Journal of Attention Disorders has provided a platform for the latest findings and discussions, supporting researchers, practitioners, and students alike. While the journal remains non-open access, it ensures rigorous dissemination of crucial information, solidifying its importance in shaping future research and best practices concerning attention disorders.

COMPREHENSIVE PSYCHIATRY

Exploring innovative solutions for mental wellness.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0010-440XFrequency: 8 issues/year

COMPREHENSIVE PSYCHIATRY is a leading peer-reviewed journal dedicated to advancing the field of psychiatry and mental health, published by W B SAUNDERS CO-ELSEVIER INC. With its Q1 designation in both Clinical Psychology and Psychiatry and Mental Health, this journal ranks impressively, holding the 9th position out of 311 in Clinical Psychology and the 27th position out of 567 in Psychiatry and Mental Health according to Scopus metrics. Since transitioning to Open Access in 2019, COMPREHENSIVE PSYCHIATRY has significantly increased its accessibility, enabling a broader audience of researchers, mental health professionals, and students to engage with cutting-edge research and clinical practices. The journal's scope encompasses a wide array of topics, including but not limited to evidence-based interventions, psychological evaluations, and the latest empirical studies in the field. As we continue to navigate the complexities of mental health in contemporary society, this journal serves as a vital resource for disseminating impactful findings and fostering collaborative discourse among scholars and practitioners globally.

BMC NEUROSCIENCE

Empowering Minds with Accessible Neuroscience Insights
Publisher: BMCISSN: 1471-2202Frequency: 1 issue/year

BMC NEUROSCIENCE is a prominent open access journal dedicated to the dissemination of high-quality research within the dynamic and rapidly evolving field of neuroscience. Published by BMC, a well-respected leader in open access publishing, this journal facilitates the free exchange of knowledge since its inception in 2000. With the ISSN 1471-2202, BMC NEUROSCIENCE aims to address the diverse interests of the neuroscience community by covering a broad spectrum of topics, ranging from cellular and molecular neuroscience to general neurological studies, thus appealing to researchers, professionals, and students alike. Although it currently holds a Q4 ranking in Cellular and Molecular Neuroscience and a Q3 rank in miscellaneous Neuroscience categories, its commitment to advancing the understanding of brain function and disorders remains steadfast. The journal features a user-friendly Open Access model, ensuring that critical research findings are readily accessible to everyone, fostering collaboration and innovation in the field. As the journal continues to evolve towards its convergence years of 2024, it aspires to enhance its impact and global reach, making it a valuable resource for anyone interested in advancing neuroscience research.

Parkinsons Disease

Leading the charge in innovative Parkinson's disease studies.
Publisher: HINDAWI LTDISSN: 2090-8083Frequency:

Parkinson's Disease is a prestigious open access journal dedicated to advancing the field of neurology with a special emphasis on Parkinson's disease and related movement disorders. Published by Hindawi Ltd, the journal has established itself as a vital resource since its inception in 2008, transitioning to an open access model in 2010. Featuring the ISSN 2090-8083 and E-ISSN 2042-0080, it has rapidly gained traction in the academic community, currently ranked Q2 in clinical neurology and psychiatry in the 2023 category quartiles, highlighting its significance and quality within the field. With Scopus rankings placing it in the top percentiles for neuroscience and psychiatry, it provides researchers, healthcare professionals, and students with cutting-edge research, reviews, and clinical studies. Situated in London, England, this journal encourages submissions that contribute to the understanding and management of Parkinson's disease, showcasing the latest findings and fostering collaboration among researchers worldwide.

CHILD PSYCHIATRY & HUMAN DEVELOPMENT

Exploring the Depths of Child Mental Health
Publisher: SPRINGERISSN: 0009-398XFrequency: 6 issues/year

CHILD PSYCHIATRY & HUMAN DEVELOPMENT, published by Springer, stands at the forefront of research in the fields of developmental and educational psychology, pediatrics, perinatology, and child psychiatry. With an ISSN of 0009-398X and an E-ISSN of 1573-3327, this esteemed journal has been a vital resource for academics since its inception in 1970. Currently ranked in the Q1 category across its multiple relevant disciplines, it illustrates a significant impact with its Scopus rankings, placing it within the top 13% for pediatrics and child health and the top 18% for developmental psychology. Its comprehensive scope ensures that leading-edge studies, reviews, and discourse are accessible, contributing greatly to the understanding of mental health and developmental processes in children. With no open access option, the journal maintains a commitment to high-quality, peer-reviewed content that is invaluable for researchers, healthcare professionals, and students alike, as they strive to advance their knowledge and practices in child psychology and human development.

MOLECULAR PSYCHIATRY

Transforming Understanding of Psychiatric Disorders through Molecular Research
Publisher: SPRINGERNATUREISSN: 1359-4184Frequency: 12 issues/year

MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.

Progress in Neurology and Psychiatry

Advancing knowledge in neurology and psychiatry.
Publisher: JOHN WILEY & SONS LTDISSN: 1367-7543Frequency: 4 issues/year

Progress in Neurology and Psychiatry is a pivotal journal published by John Wiley & Sons Ltd, dedicated to advancing the fields of neurology and psychiatry. With a robust history dating back to its establishment, this esteemed journal holds a consistent Q3 ranking in 2023 across several categories including Neurology, Clinical Neurology, Psychiatry, and Mental Health, signifying its significant contribution to the scientific community. This journal serves as a vital source of knowledge and insight, publishing original research, reviews, and case studies that explore the intricacies of neurological and psychiatric disorders. Although it does not offer open access, the journal remains accessible to a wide audience through institutional subscriptions. By fostering a platform for scholarly discourse, Progress in Neurology and Psychiatry aims to bridge the gap between research and practice, ultimately enhancing the quality of care for individuals with neurological and psychiatric conditions. Researchers, clinicians, and students are encouraged to engage with the journal's comprehensive content to stay informed of the latest developments and emerging trends in these critical fields of medicine.